导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 4.55% | 173/344 |
| 近一周 | 0.11% | 22/350 |
| 近一月 | -0.68% | 69/350 |
| 近一季 | 6.53% | 61/350 |
| 近半年 | 7.19% | 159/346 |
| 近一年 | 16.71% | 75/339 |
| 近两年 | 6.14% | 267/304 |
| 近三年 | 22.00% | 160/240 |
| 成立以来 | 138.31% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-3.80% 117/360 |
5.62% 161/366 |
- - |
- - |
| 2025 | 14.07% 244/358 |
5.57% 136/340 |
-5.12% 325/348 |
3.13% 326/354 |
10.44% 15/358 |
| 2024 | 0.16% 227/329 |
5.19% 134/280 |
-0.30% 200/310 |
6.58% 141/318 |
-10.40% 294/329 |
| 2023 | 2.40% 115/275 |
-1.95% 164/205 |
2.65% 110/230 |
-2.38% 32/262 |
4.23% 142/276 |
| 2022 | -2.65% 20/201 |
-1.80% 16/153 |
-5.27% 74/164 |
-6.28% 83/189 |
11.66% 91/202 |
| 2021 | 18.22% 45/150 |
0.60% 186/312 |
7.53% 103/328 |
0.03% 96/358 |
9.24% 35/151 |
| 2020 | 9.89% 41/103 |
-10.95% 135/280 |
11.84% 156/295 |
4.04% 107/299 |
6.06% 193/305 |
| 2019 | 20.81% 43/88 |
7.73% 160/258 |
1.15% 143/268 |
-1.00% 173/253 |
11.99% 38/266 |
| 2018 | 1.25% 14/79 |
- - |
- - |
- - |
-8.85% 105/241 |
| 2017 | 18.28% 32/69 |
- - |
- - |
- - |
- - |
| 2016 | -7.48% 44/59 |
- - |
- - |
- - |
- - |
| 2015 | 5.36% 14/49 |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 广发中证香港创新药ETF(QDII) | 1.2744 | 27.49% |
| 广发道琼斯石油指数美元现汇A | 0.4802 | 27.44% |
| 广发道琼斯石油指数美元现汇C | 0.4718 | 27.38% |
| 广发道琼斯石油指数(QDII-LOF)美元现汇E | 0.4729 | 27.33% |
| 广发道琼斯石油指数人民币A | 3.2498 | 26.68% |
| 广发道琼斯石油指数人民币C | 3.1927 | 26.58% |
| 广发道琼斯石油指数(QDII-LOF)人民币E | 3.2003 | 26.55% |
| 广发中证香港创新药ETF发起式联接(QDII)C | 1.3286 | 26.01% |
| 富国标普石油天然气勘探及生产精选行业ETF(QDII) | 1.4105 | 25.68% |
| 汇添富恒生生物科技ETF(QDII) | 1.1055 | 25.31% |
| 广发全球医疗保健美元现汇(QDII)A VS. 建信富时100指数(QDII)人民币A(539003) |